Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BRAIN Biotech is a leading European industrial biotechnology company that specializes in the development of innovative bio-based products and solutions for the nutrition, health, and environment sectors. The company leverages its proprietary metagenomic library, which contains over 300 million unique enzyme sequences, to discover and engineer specialty enzymes and microbial production strains. Through its BRAINBioIncubator segment, the company advances a pipeline of high-value research projects, including novel CRISPR-based genome editing tools and enzymatic wound care treatments. BRAIN Biotech operates its own fermentation facilities and provides contract research and development services to global pharmaceutical and chemical partners. Headquartered in Zwingenberg, Germany, the company is publicly traded on the Frankfurt Stock Exchange and is a key player in the transition to a sustainable, bio-based economy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biotech groups.